Abstract
The incidence and prevalence ofToxoplasma gondii andPneumocystis carinii infections among AIDS patients in Europe are different from those observed in the USA. These differences are probably causally related to differences in host exposure, and sociocultural and nutritional habits.
Similar content being viewed by others
References
World Health Organization Collaborating Centre on AIDS AIDS surveillance in Europe. World Health Organization, Paris, Q Report No. 23, September 30, 1989.
World Health Organization Collaborating Centre on AIDS AIDS surveillance in the European Community. World Health Organization, Paris, Q Report No. 23, December 30, 1989.
Selik RM, Starcher ET, Curran JW Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1987, 1: 175–182.
McCabe R, Remington JS Toxoplasmosis: the time has come. New England Journal of Medicine 1988, 318: 313–315.
Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Annals of Neurology 1986, 19: 224–238.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clumeck, N. Some aspects of the epidemiology of toxoplasmosis and pneumocystosis in AIDS in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 10, 177–178 (1991). https://doi.org/10.1007/BF01964454
Issue Date:
DOI: https://doi.org/10.1007/BF01964454